Ondine Biomedical (FRA:VF5) Days Payable: 799.72 (As of Dec. 2024)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.15
View Full Analysis

What is Ondine Biomedical Days Payable?

Ondine Biomedical FRA:VF5 -23.08% 47 Days Payable is 799.72 as of Dec. 2024. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

Ondine Biomedical's average Accounts Payable for the six months ended in Dec. 2024 was €1.17 Mil. Ondine Biomedical's Cost of Goods Sold for the six months ended in Dec. 2024 was €0.27 Mil. Hence, Ondine Biomedical's Days Payable for the six months ended in Dec. 2024 was 799.72.

The historical rank and industry rank for Ondine Biomedical's Days Payable or its related term are showing as below:

FRA:VF5's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Ondine Biomedical's Days Payable increased from Dec. 2023 (451.71) to Dec. 2024 (799.72). It may suggest that Ondine Biomedical delayed paying its suppliers.

Ondine Biomedical Days Payable Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Days Payable Chart

Ondine Biomedical Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.97 197.36 823.49 643.30 746.08

Ondine Biomedical Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 401.05 320.49 451.71 903.91 799.72

FRA:VF5 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Ondine Biomedical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Days Payable distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Days Payable falls into.


FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ondine Biomedical's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

Days Payable (A: Dec. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2023 ) + Accounts Payable (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (0.932 + 1.063) / 2 ) / 0.488*365
=0.9975 / 0.488*365
=746.08

Ondine Biomedical's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

Days Payable (Q: Dec. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2024 ) + Accounts Payable (Q: Dec. 2024 )) / count ) / Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=( (1.277 + 1.063) / 2 ) / 0.267*365 / 2
=1.17 / 0.267*365 / 2
=799.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 799.72 mean?
Ondine Biomedical (FRA:VF5) has a Days Payable of 799.72 as of Dec. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Days Payable too high?
Ondine Biomedical's current Days Payable is 799.72. The Biotechnology industry median Days Payable is 113.56. Ondine Biomedical's value of 799.72 is 604.2% above this industry median. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Days Payable compare to VRTX and REGN?
Ondine Biomedical's Days Payable of 799.72 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.56. Ondine Biomedical's value of 799.72 is 604.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ondine Biomedical's current Days Payable of 799.72 is 604.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ondine Biomedical and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ondine Biomedical's current Days Payable is 799.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current Days Payable of 799.72. The current Days Payable is 799.72 and 604.2% above the Biotechnology industry median of 113.56. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current Days Payable is 799.72 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price